Farxiga and

Farxiga (generic: dapagliflozin) is a type 2 diabetes medication that is taken orally to keep blood sugar levels steady. It uses SGLT2 inhibitors to help the kidneys get rid of extra glucose in the bloodstream and prevent them from absorbing this excess glucose. Glucose inhibited from entering the bloodstream exits the body via urine, lowering the patient’s blood glucose levels.

Since the drug’s approval in 2014, the FDA has issued warnings associated with Farxiga and other SGLT2 inhibitors that these drugs can cause a life-threatening condition: ketoacidosis. If this happened to you, you may want to consider a Farxiga lawsuit. At this time, GoldenbergLaw is no longer accepting Farxiga cases.

Case Quick Facts

The Problem

Farxiga can cause a build-up of acids (ketones) in the bloodstream, which can lead to ketoacidosis. If you took Farxiga and got ketoacidosis, contact one of our Farxiga lawyers to see how we can help.

The Injuries

Injuries associated with the usage of Farxiga and other SGLT2 inhibitors leading to ketoacidosis include:

  • Low blood sugar
  • Fluid buildup in the brain
  • Kidney failure
  • Cardiac arrest
  • Coma or death (if left untreated)
The Defendant(s)

The following SGLT2 inhibitor medications are involved in multidistrict litigation for the unwarned of side effect of diabetic ketoacidosis:

  • Farxiga (dapagliflozin)
  • Xigduo XR (dapagliflozin and metformin HCl)
  • Invokana/Invokamet (canagliflozin and metformin)
  • Jardiance (empagliflozin)
  • Glyxambi (empagliflozin and linagliptin)
  • Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals LP, AstraZeneca PLC, and AstraZeneca AB manufactured Farxiga and Xigduo XR.
  • Janssen Pharmaceuticals manufactured Invokana/Invokamet
  • Boehringer Ingelheim and Lilly manufactured Jardiance and Glyxambi.
GoldenbergLaw Can Help

In April 2017, a multidistrict litigation (MDL) was created regarding the dangerous side effects of Farxiga and Xigduo XR. The MDL was assigned to New York Federal Court Judge Lorna Schofield. Laura Pittner of GoldenbergLaw was appointed to the Plaintiff Steering Committee in the Farxiga MDL.


Free Consultation

If you are considering filing for a defective pharmaceutical product lawsuit, GoldenbergLaw is here to help. We only care about helping those who need us, so consultations are free of charge and obligation.

Contact Us Call 800-903-1643
Biohazard icon

FDA Warnings and Safety Concerns

June 2016: The FDA required makers of Farxiga and Xigduo XR to strengthen the warning regarding acute kidney injury.

May 2015: The FDA issued a warning that SGLT2-inhibiting medications, such as Farxiga, may lead to increased risks of ketoacidosis. The warning required manufacturers to indicate an increased risk of ketoacidosis on the drug labels.

Why Choose GoldenbergLaw?

GoldenbergLaw has the experience necessary to handle your problem. We have worked with cases in the pharmaceutical world for years, and we have experienced lawyers that can handle your case with expertise. Contact us today to see what we can do for you.

Over 30 Years of Experience

Admissions in Courts Nationwide

Compassion and Respect for Clients

Meet Your Farxiga Team

Attorney Referral

Have a potential client we could help?

Referral Form

Free Consultation

Call us. You’ll sleep better.

Schedule Now